Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycophenolate mofetil: selective T cell inhibition.

Robert W McMurray1, Valee Harisdangkul

  • 1Rheumatology Section, Medical Service, G.V (Sonny) Montgomery VA Medical Center, Jackson, Mississippi 39216, USA. robert.mcmurray@med.va.gov

The American Journal of the Medical Sciences
|May 11, 2002
PubMed
Summary

Mycophenolate mofetil suppresses T cell proliferation and adhesion by inhibiting a key purine salvage pathway. Its potential as an antirheumatic agent for rheumatoid arthritis warrants further investigation due to promising preliminary results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of cyclic versus sustained estrogen administration on peripheral immune functions in ovariectomized mice.

American journal of reproductive immunology (New York, N.Y. : 1989)·2010
Same author

Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model.

Clinical immunology (Orlando, Fla.)·2007
Same author

Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice.

International immunopharmacology·2006
Same author

Coumestrol, bisphenol-A, DDT, and TCDD modulation of interleukin-2 expression in activated CD+4 Jurkat T cells.

International journal of environmental research and public health·2006
Same author

Molecular and cellular mechanisms associated with autoimmune diseases.

International journal of environmental research and public health·2006
Same author

Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental-two case reports and review of the literature.

Clinical rheumatology·2005

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • T cells play a role in rheumatoid arthritis (RA) pathogenesis.
  • Mycophenolate mofetil is an established immunosuppressant with a favorable risk/benefit profile.
  • Preliminary data suggests efficacy in RA patients.

Purpose of the Study:

  • To investigate the therapeutic potential of mycophenolate mofetil in rheumatoid arthritis.
  • To evaluate its role in suppressing synovial inflammation.

Main Methods:

  • Inhibition of inosine monophosphate dehydrogenase (IMPDH) by mycophenolate mofetil.
  • Suppression of T cell proliferation and adhesion.

Main Results:

  • Mycophenolate mofetil targets a critical purine salvage pathway in T lymphocytes.

Related Experiment Videos

  • Preliminary reports indicate successful use in RA patients.
  • Demonstrates potential for suppressing synovial inflammation.

    • Conclusions:

    • Mycophenolate mofetil shows promise as a novel antirheumatic agent for RA.
    • Further research is needed to confirm its efficacy and safety in RA.
    • Its established safety and efficacy in transplantation support its potential in rheumatic diseases.